The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Deferoxamine mesylate
Deferoxamine mesylate · DEFEROXAMINE MESYLATE 2 g/1 · Injection, Powder, Lyophilized, For Solution · Intramuscular; Intravenous · Apotex Corp.
NDC 60505-6237-06 · 4 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$164.80
Reported to Texas DSHS · 2026 annual filing · Apotex Corp
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Medicaid spend (2025)
$35,276
304 prescriptions paid by Medicaid nationally · all Medicaid spend →
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill · avg $249.55 per prescription
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- ANDA207384
- TE code
- AP
- Approval date
- Sep 29, 2017
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Deferoxamine mesylate (Injection, Powder, Lyophilized, For Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Apotex Corp. | DEFEROXAMINE MESYLATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Apotex Corp. | DEFEROXAMINE MESYLATE 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | DEFEROXAMINE MESYLATE 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Gland Pharma Limited | DEFEROXAMINE MESYLATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Hospira, Inc. | DEFEROXAMINE MESYLATE 2 g/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novartis Pharmaceuticals Corporation | DEFEROXAMINE MESYLATE 500 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Fresenius Kabi USA, LLC | DEFEROXAMINE MESYLATE 95 mg/mL | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Deferoxamine mesylate — NDC 60505-6237-06," retrieved September 3, 2026, https://drugdashboards.com/drug/60505623706.
Free to cite with attribution — see how the data is put together.